Hospital-Acquired Antibiotic-Resistant Infections Triple Costs And Lengths Of Hospitalization

September 29, 1997

TORONTO -- Duke University Medical Center researchers have put a price tag on the most common hospital-acquired infections that can prolong and increase the cost of a patient's stay in the hospital.

The researchers studied patients who got bloodstream infections in the hospital caused by Staphylococcus aureus (S. aureus), one of the most commonly encountered bacteria in hospitals, and found that strains of the bacteria resistant to the commonly-used antibiotic methicilin tripled both the cost of hospitalization and the length of stay when compared to S. aureus strains susceptible to the antibiotic.

"We found that average hospital stay due to methicilin-resistant S. aureus (MRSA) was 12 days longer, compared to four days longer for methicilin-susceptible S. aureus (MSSA)," said Dr. Murray Abramson, Duke infectious disease physician who conducted the study. "In terms of added cost, the average due to MRSA infections was $27,082, compared to $9,661 for MSSA.

Abramson prepared his results for presentation Sunday at the annual meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy.

The Centers for Disease Control and Prevention estimates that more than 2 million Americans each year acquire nosocomial, or in-hospital, infections, and between 60,000 and 80,000 die. The culprit in the majority of the cases is S. aureus, which typically enters patients through surgical wounds and intravenous line sites, and can be passed very easily from person to person.

In 1981, according to Abramson, about 5 percent of S. aureus in hospitals were methicilin resistant; by 1991 the percentage had grown to 38 percent, and he estimates that today about half are resistant to the antibiotic at many medical institutions.

"Antibiotic-resistant bacteria is a major problem we face in hospitals, but it is one we can get a handle on with common-sense precautions," Abramson said. "Since the bacteria are everywhere, such things as hand-washing and maintaining good IV sites help. The solutions are out there."

In his analysis, Abramson looked at all the patients with primary in-hospital infections during a 15-month period in 1994-1995. Of those, 19 met study requirements -- eight with MRSA and 11 with MSSA. Researchers then found 19 patients without nosocomial infections who specifically matched study participants in such characteristics as age, sex, primary and secondary diagnoses and hospital units.

By comparing the hospitalizations and costs of the two groups of patients, researchers were able to determine the extra costs associated with the in-hospital infections.

"The differences between the MRSA and the MSSA group was striking," Abramson said. "As infectious disease physicians, we knew that these patients had longer hospitalizations, but we didn't know how much these infections added to the total costs. We estimate that close to $321,000 could have been saved had these 19 patients not acquired these nosocomial infections."

In addition to improving hospital hygiene, physicians should use antibiotics more appropriately, Abramson said. When antibiotics are used indiscriminately, bacteria with mild resistance can develop and pass this resistance to other bacteria, creating newer strains that become increasingly resistant to the antibiotic.

As an example, Abramson cited penicillin, the first effective antibiotic. "When penicillin was first introduced in the 1940s, it was effective against almost all S. aureus strains. Today, about 99 percent of S. aureus is resistant to penicillin."

The study, supported by Duke's Division of Infectious Disease, also included Dr. Daniel Sexton, Melissa Bronstein, RN, Mary Oden, RN, and Stephanie Weaver, RN.
-end-


Duke University Medical Center

Related Bacteria Articles from Brightsurf:

Siblings can also differ from one another in bacteria
A research team from the University of Tübingen and the German Center for Infection Research (DZIF) is investigating how pathogens influence the immune response of their host with genetic variation.

How bacteria fertilize soya
Soya and clover have their very own fertiliser factories in their roots, where bacteria manufacture ammonium, which is crucial for plant growth.

Bacteria might help other bacteria to tolerate antibiotics better
A new paper by the Dynamical Systems Biology lab at UPF shows that the response by bacteria to antibiotics may depend on other species of bacteria they live with, in such a way that some bacteria may make others more tolerant to antibiotics.

Two-faced bacteria
The gut microbiome, which is a collection of numerous beneficial bacteria species, is key to our overall well-being and good health.

Microcensus in bacteria
Bacillus subtilis can determine proportions of different groups within a mixed population.

Right beneath the skin we all have the same bacteria
In the dermis skin layer, the same bacteria are found across age and gender.

Bacteria must be 'stressed out' to divide
Bacterial cell division is controlled by both enzymatic activity and mechanical forces, which work together to control its timing and location, a new study from EPFL finds.

How bees live with bacteria
More than 90 percent of all bee species are not organized in colonies, but fight their way through life alone.

The bacteria building your baby
Australian researchers have laid to rest a longstanding controversy: is the womb sterile?

Hopping bacteria
Scientists have long known that key models of bacterial movement in real-world conditions are flawed.

Read More: Bacteria News and Bacteria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.